Preface: Psoriasis Today—A New Paradigm

Abstract

Get full access to this article

View all access options for this article.

References

Krueger

Koo

Lebwohl

. The impact of psoriasis on quality of life. Arch Dermatol 2001; 137:280–284.

Rapp

Feldman

Exum

. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401–407.

Henseler

Christophers

. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32:982–986.

Krueger

Callis

. Development and use of alefacept to treat psoriasis. J Am Acad Dermatol 2003; 49 Suppl:S87–S97.

Feldman

Menter

Koo

. Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis. Br J Dermatol 2004; 150:317–326.

Ellis

Krueger

. Treatment of chronic plaque psoriasis by selective targeting of memory-effector T-lymphocytes. N Engl J Med 2001; 345:248–255.

Margolis

Bilker

Hennessy

. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137:778–783.

Hannuksela-Svahn

Pukkala

Laara

. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114:587–590.